Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study

JAMA Psychiatry

Volumn 70, Issue 3, 2013, Pages 319-324

  McKetin, Rebecca ^a,b   Lubman, Dan I ^c   Baker, Amanda L ^d   Dawe, Sharon ^e   Ali, Robert L ^f  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

^f UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; METHAMPHETAMINE; OPIATE;

ADULT; ALCOHOLISM; ARTICLE; AUSTRALIA; BRIEF PSYCHIATRIC RATING SCALE; CANNABIS ADDICTION; DISEASE ASSOCIATION; DOSE RESPONSE; DSM-IV; FEMALE; HALLUCINATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; METHAMPHETAMINE DEPENDENCE; PROSPECTIVE STUDY; PSYCHOSIS; SCHIZOPHRENIA;

EID: 84874885884     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.283     Document Type: Article

References (41)

1. United Nations Office on Drugs and Crime. World Drug Report 2010. New York, NY: United Nations; 2010.
2. Harris D, Batki SL. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict. 2000;9(1):28-37. (Pubitemid 30155031)
3. Davis J, Schlemmer RF. The amphetamine psychosis. In: Caldwell J, ed. Amphetamine and Related Stimulants: Chemical, Biological, Clinical and Sociological Aspects. Boca Raton, FL: CRC Press; 1980:161-173.
4. Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res. 1974;11:13-23.
5. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996; 91(1):81-87. (Pubitemid 26026812)
6. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, Taylor C. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry. 2002;181:393-398. (Pubitemid 35333106)
7. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, Iguchi M; Methamphetamine Treatment Project. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13(2):181-190. (Pubitemid 38585698)
8. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101(10):1473-1478. (Pubitemid 44337772)
9. Smith MJ, Thirthalli J, Abdallah AB, Murray RM, Cottler LB. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry. 2009;50(3):245-250.
10. McKetin R, Hickey K, Devlin K, Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alcohol Rev. 2010; 29(4):358-363.
11. Sara GE, Burgess PM, Harris MG, Malhi GS, Whiteford HA. Stimulant use and stimulant use disorders in Australia: findings from the National Survey of Mental Health and Wellbeing. Med J Aust. 2011;195(10):607-609.
12. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004; 2:13.
13. McGrath JJ. The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry. 2007;64(1):14-16. (Pubitemid 46041734)
14. Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev. 2007;27(4):494-510. (Pubitemid 46431229)
15. Seedat S, Stein MB, Oosthuizen PP, Emsley RA, Stein DJ. Linking posttraumatic stress disorder and psychosis: a look at epidemiology, phenomenology, and treatment. J Nerv Ment Dis. 2003;191(10):675-681. (Pubitemid 37296180)
16. Hasin D, Nunes EV,Meydan J. Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology. In: Kranzler HR, Tinsley JA, eds. Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders. 2nd ed. New York, NY: Marcel Dekker; 2004:1-34.
17. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: the National Comorbidity Survey. Arch Gen Psychiatry. 1996;53(11):1022-1031. (Pubitemid 26384671)
18. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol Med. 2006;36(2):231-238. (Pubitemid 43126147)
19. Fergusson DM, Swain-Campbell NR, Horwood LJ. Deviant peer affiliations, crime and substance use: a fixed effects regression analysis. J Abnorm Child Psychol. 2002;30(4):419-430. (Pubitemid 38471290)
20. Livingston M. A longitudinal analysis of alcohol outlet density and domestic violence. Addiction. 2011;106(5):919-925.
21. McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, Lee NK, Mattick RP, Mamun A. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction. 2012;107(11):1998-2008.
22. Andrews G, Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol. 1998;33(2): 80-88. (Pubitemid 28080588)
23. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12(4):578-602.
24. Ventura J, Green MF, Shaner A, Liberman RP. Training and quality assurance with the Brief Psychiatric Rating Scale: 'the drift busters.' Int J Methods Psychiatr Res. 1993;3:221-244.
25. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733-742.
26. Ware JE, Kosinski M, Keller SD. How to Score the SF-12 Physical and Mental Health Summary Scales. 2nd ed. Boston, MA: The Health Institute, New England Medical Centre; 1995.
27. Stata Special Edition (forWindows) [computer program]. Version 11.2. College Station, TX: StataCorp; 2012.
28. Mathias S, Lubman DI, Hides L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry. 2008;69(3):358-367. (Pubitemid 351549387)
29. Shoptaw SJ, Kao U, Ling W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev. 2009;(1):CD003026.
30. Knapp WP, Soares BGO, Farrel M, Lima MS. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev. 2007;(3):CD003023.
31. Colfax G, Santos GM, Chu P, Vittinghoff E, Pluddemann A, Kumar S, Hart C. Amphetamine-group substances and HIV. Lancet. 2010;376(9739):458-474.
32. Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonaldM, DiMaria J, Lucero L, Kellogg S. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry. 2006;163 (11):1993-1999. (Pubitemid 44807792)
33. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, Veniegas RC, Freese TE, Hucks-Ortiz C. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 2005;78(2):125-134. (Pubitemid 40544599)
34. Shoptaw S, Reback CJ, Larkins S, Wang PC, Rotheram-Fuller E, Dang J, Yang X. Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men. J Subst Abuse Treat. 2008;35(3):285-293.
35. Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2005;136B(1):87- 91. (Pubitemid 40917535)
36. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci. 1992;654:160-170.
37. Freeman D, Stahl D, McManus S, Meltzer H, Brugha T, Wiles N, Bebbington P. Insomnia, worry, anxiety and depression as predictors of the occurrence and persistence of paranoid thinking. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(8):1195-1203.
38. West LJ, Janszen HH, Lester BK, Lester BK, Cornelisoon FS Jr. The psychosis of sleep deprivation. Ann N Y Acad Sci. 1962;96:66-70.
39. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184: 110-117. (Pubitemid 38186851)
40. Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973;29(1):35-40.
41. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511- 2518.